InvestSMART

CurveBeam AI Limited (ASX:CVB)

ALERT: Price-sensitive ASX Announcement for CVB
Current share price for CVB : $0.017 -0.001 (-5.56%)+
Announcement
Release
8 Jul 2026 9:33AM
Price at Release
$0.018
Full Release
download
Summary
CurveBeam AI Limited, listed on the ASX as CVB, reported its financial and operational activities for the quarter ending June 30, 2026. The company secured two purchase orders for its HiRise™ systems during the quarter and anticipates more sales opportunities in the upcoming quarter. Customer receipts doubled from the previous quarter to A$2.58 million. The company is progressing in its regulatory approval process in China with the NMPA for its HiRise™ product, which could trigger significant milestone payments upon clearance and subsequent sales. Cash at the end of the quarter was A$1.64 million, with an expected improvement following a capital raise. The company continues to collaborate on validation activities for its HiRise™ systems with leading robotic surgery platforms. These developments are set against a backdrop of ongoing efforts to enhance market penetration in China, supported by a strategic partnership with WEGO Orthopaedics and preparations for the commercial launch in the region.
Key Points
  • CurveBeam AI secured two HiRise™ system purchase orders in Q4 FY26.
  • Customer receipts increased by 80% compared to the previous quarter.
  • Regulatory progress in China is ongoing with NMPA for HiRise™.
  • Cash position at the end of the quarter was A$1.64 million.
  • Expected cash improvement due to a capital raise and milestone payments.
  • Collaboration with robotic surgery platforms continues for HiRise™.
  • Commercial launch preparations in China are advancing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.